/Tag: Biological

NBM ANNOUNCES RECEIVING INVENTION PATENT, TITLED “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES”, FROM ISRAELI’S PATENT OFFICE

The Israeli’s Patent Office approved the application of “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES” from NBM for an invention patent with the certificate No. 231754. Prenylflavanone compounds have been used in NBM’s product, SugarBless, for blood sugar control.

2018-05-25T18:39:44+00:00 2018 / 05 / 18|Categories: News|Tags: |

NBM ANNOUNCES RECEIVING THE US INVENTION PATENT FOR “EXTRACT OF TAIWANESE PROPOLIS FOR TREATING OCULAR DISEASES”

The US Patent Invention No. 14/632,894 "EXTRACT OF TAIWANESE PROPOLIS FOR TREATING OCULAR DISEASES" filed by NatureWise was approved by the U.S. Patent and Trademark Office. Frequent usage of 3C products lead to eye damage. Our extract of Taiwanese green propolis has been found to protect the eye.

2018-05-25T18:37:20+00:00 2018 / 01 / 04|Categories: News|Tags: |

CITY OF HOPE, NATUREWISE ANNOUNCE LICENSE AGREEMENT FOR NEW TARGETED CANCER THERAPY

NatureWise will commercially develop HDAC8 inhibitors patented by City of Hope, collaborators.   City of Hope today announced that it has licensed its HDAC8 inhibitors patent exclusively to NatureWise Biotech & Medicals Corporation, a pharmaceutical company in Taipei, Taiwan.   Read more: https://www.cityofhope.org/news/city-of-hope-naturewise-announce-license-agreement

2018-05-25T18:46:25+00:00 2016 / 09 / 30|Categories: News|Tags: |
error: Content is protected !!